PF-04878691
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for PF-04878691, covering 2009-12-01 to 2009-12-01. Get the full timeline:
Most recent: Clinical Trial Update: Multiple Oral Dose Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of PF-04878691 [Phase 1]